Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,728 | 0 | 0 | 0 | 27,332 |
| Other current assets | 0 | 0 | 0 | 0 | 7 |
| TOTAL | $45,071 | $0 | $0 | $0 | $27,339 |
| Non-Current Assets | |||||
| PPE Net | 77 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 513 | 0 | 0 | 0 | 0 |
| TOTAL | $590 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $45,661 | $0 | $0 | $0 | $27,339 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 202 | 0 | 0 | 0 | 69 |
| Accrued Expenses | 1,596 | 0 | 0 | 0 | 469 |
| Other current liabilities | N/A | 0 | 0 | 0 | 1,483 |
| TOTAL | $1,996 | $0 | $0 | $0 | $2,021 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 99,082 | 1,018 | 649 | 457 | 35,991 |
| TOTAL | $97,870 | $N/A | $N/A | $N/A | $35,991 |
| Total Liabilities | $99,866 | $0 | $0 | $0 | $38,012 |
| Shareholders' Equity | |||||
| Common Shares | 2,000 | 0 | 0 | 0 | 2,000 |
| Retained earnings | -56,842 | 0 | 0 | 0 | -12,784 |
| Other shareholders' equity | 637 | 0 | 0 | 0 | 111 |
| TOTAL | $-54,205 | $0 | $0 | $0 | $-10,673 |
| Total Liabilities And Equity | $45,661 | $0 | $0 | $0 | $27,339 |